6-AMino-5-azacytidine
- $200 - $1260
- Product name: 6-AMino-5-azacytidine
- CAS: 105331-00-8
- MF: C8H13N5O5
- MW: 259.22
- EINECS:
- MDL Number:MFCD30186651
- Synonyms:6-AMino-5-azacytidine;4,6-Diamino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;4,6-Diamino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;4,6-diamino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;4,6-diamino-1-((2R,3R,4S,5R);1,3,5-Triazin-2(1H)-one, 4,6-diamino-1-β-D-ribofuranosyl-;Azacitidine Impurity ABCDEFG;6-Amino-5-azacytidine formate salt
3 prices
Selected condition:
Brand
- ChemScene
- TRC
Package
- 5mg
- 10mg
- 50mg
- ManufacturerChemScene
- Product numberCS-0089197
- Product description6-Amino-5-azacytidine
- Packaging5mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0089197
- Product description6-Amino-5-azacytidine
- Packaging10mg
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA604100
- Product description6-Amino-5-azacytidine
- Packaging50mg
- Price$1260
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ChemScene | CS-0089197 | 6-Amino-5-azacytidine | 5mg | $200 | 2021-12-16 | Buy |
ChemScene | CS-0089197 | 6-Amino-5-azacytidine | 10mg | $350 | 2021-12-16 | Buy |
TRC | A604100 | 6-Amino-5-azacytidine | 50mg | $1260 | 2021-12-16 | Buy |
Properties
Melting point :240-242 °C (decomp)
Boiling point :580.3±60.0 °C(Predicted)
Density :2.27±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
form :Solid
pka :13.46±0.70(Predicted)
color :White to off-white
Water Solubility :Water: 14.71 mg/mL (56.75 mM)
Boiling point :580.3±60.0 °C(Predicted)
Density :2.27±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
form :Solid
pka :13.46±0.70(Predicted)
color :White to off-white
Water Solubility :Water: 14.71 mg/mL (56.75 mM)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|